Biopharma companies spend thousands of dollars on consultants and agencies to “map the patient journey.” Oftentimes these exercises are recommissioned year after year.
For years pharma has said it needs to be more focused on patients, has it delivered?
Get the most out of
Register for free and enjoy unlimited access to:
